Proguanil

DRUG2 trials

Sponsors

London School of Hygiene and Tropical Medicine, University of Southern Denmark

Conditions

CYP2C19 GenotypesMalariaSickle Cell Crisis

Phase 1

Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell Disease

CompletedNCT01319448

London School of Hygiene and Tropical MedicineMalaria, Sickle Cell Crisis

Start: 2011-09-30End: 2013-04-30Updated: 2014-03-21

Impact of CYP2C19*17 on the Pharmacokinetics of Proguanil and Clopidogrel

CompletedNCT01456546

University of Southern DenmarkCYP2C19 Genotypes

Start: 2011-10-31End: 2013-07-31Updated: 2013-07-03

Related Papers

A Randomized Trial to Compare the Safety, Tolerability, and Effectiveness of 3 Antimalarial Regimens for the Prevention of Malaria in Nigerian Patients With Sickle Cell Disease

The Journal of Infectious Diseases2015-02-2018 citations